{"DataElement":{"publicId":"6479322","version":"1","preferredName":"Merkel Cell Cancer AJCC Edition 8 Clinical Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for merkel cell carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"MCC_AJC8_CLN_N_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6477687","version":"1","preferredName":"Merkel Cell Neoplasm Clinical N Category","preferredDefinition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"6477683v1.0:2428496v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6477683","version":"1","preferredName":"Merkel Cell Neoplasm","preferredDefinition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12592:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell","conceptCode":"C12592","definition":"An epidermal cell, primarily located in the basal layer, that is thought to function in tactile sensory perception.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E3EF07-8EE9-4141-E053-F662850A90EE","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"77E3EF07-8F16-4141-E053-F662850A90EE","latestVersionIndicator":"Yes","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-10-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6477779","version":"1","preferredName":"Merkel Cell Carcinoma American Joint Committee on Cancer Edition 8 Clinical N Category","preferredDefinition":"A clinical finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6477779v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3","valueDescription":"Merkel Cell Carcinoma cN3 TNM Finding v8","ValueMeaning":{"publicId":"6477781","version":"1","preferredName":"Merkel Cell Carcinoma cN3 TNM Finding v8","longName":"6477781","preferredDefinition":"Merkel cell carcinoma with in-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cN3 TNM Finding v8","conceptCode":"C136853","definition":"Merkel cell carcinoma with in-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) with lymph node metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F53096-66A1-5DD9-E053-F662850A9E26","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F53096-66BA-5DD9-E053-F662850A9E26","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"N2","valueDescription":"Merkel Cell Carcinoma cN2 TNM Finding v8","ValueMeaning":{"publicId":"6477783","version":"1","preferredName":"Merkel Cell Carcinoma cN2 TNM Finding v8","longName":"6477783","preferredDefinition":"Merkel cell carcinoma with in-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cN2 TNM Finding v8","conceptCode":"C136852","definition":"Merkel cell carcinoma with in-transit metastasis (discontinuous from primary tumor; located between primary tumor and draining regional nodal basin, or distal to the primary tumor) without lymph node metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F53096-66C7-5DD9-E053-F662850A9E26","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F53096-66E0-5DD9-E053-F662850A9E26","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"N1","valueDescription":"Merkel Cell Carcinoma cN1 TNM Finding v8","ValueMeaning":{"publicId":"6477785","version":"1","preferredName":"Merkel Cell Carcinoma cN1 TNM Finding v8","longName":"6477785","preferredDefinition":"Merkel cell carcinoma with metastasis in regional lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cN1 TNM Finding v8","conceptCode":"C136851","definition":"Merkel cell carcinoma with metastasis in regional lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F53096-66ED-5DD9-E053-F662850A9E26","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F53096-6706-5DD9-E053-F662850A9E26","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"N0","valueDescription":"Merkel Cell Carcinoma cN0 TNM Finding v8","ValueMeaning":{"publicId":"6477787","version":"1","preferredName":"Merkel Cell Carcinoma cN0 TNM Finding v8","longName":"6477787","preferredDefinition":"Merkel cell carcinoma without regional lymph node metastasis detected on clinical and/or radiologic examination. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cN0 TNM Finding v8","conceptCode":"C136850","definition":"Merkel cell carcinoma without regional lymph node metastasis detected on clinical and/or radiologic examination. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F53096-6713-5DD9-E053-F662850A9E26","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F53096-672C-5DD9-E053-F662850A9E26","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"},{"value":"NX","valueDescription":"Merkel Cell Carcinoma cNX TNM Finding v8","ValueMeaning":{"publicId":"6477789","version":"1","preferredName":"Merkel Cell Carcinoma cNX TNM Finding v8","longName":"6477789","preferredDefinition":"Merkel cell carcinoma in which the lymph nodes cannot be clinically assessed (e.g., previously removed for another reason, or because of body habitus). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma cNX TNM Finding v8","conceptCode":"C136849","definition":"Merkel cell carcinoma in which the regional lymph nodes cannot be clinically assessed (e.g., previously removed for another reason, or because of body habitus). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77F53096-6739-5DD9-E053-F662850A9E26","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77F53096-6752-5DD9-E053-F662850A9E26","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6477791","version":"1","preferredName":"Merkel Cell Carcinoma Clinical Regional Lymph Nodes TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A clinical finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C136848:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma Clinical Regional Lymph Nodes TNM Finding v8","conceptCode":"C136848","definition":"A clinical finding about one or more characteristics of Merkel cell carcinoma, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77E47C09-0931-4E79-E053-F662850A6364","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"ONEDATA","dateModified":"2018-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"77F53096-6685-5DD9-E053-F662850A9E26","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-11-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6477698","version":"1","longName":"Merkel Cell","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical N category","type":"Preferred Question Text","description":"Clinical N category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"77F7467E-94C1-08FD-E053-F662850AA222","latestVersionIndicator":"Yes","beginDate":"2018-10-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-11","modifiedBy":"TAYLORT","dateModified":"2018-10-18","changeDescription":"10-18-2018 Changed from Draft New to Released/tmt. 10-11-18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}